Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-16T20:40:19.662Z Has data issue: false hasContentIssue false

The Dexamethasone Suppression Test in Depression

A WORLD HEALTH ORGANIZATION COLLABORATIVE STUDY

Published online by Cambridge University Press:  02 January 2018

Alec Coppen*
Affiliation:
West Park Hospital, Epsom, Surrey KT19 8PB
Maryse Metcalfe
Affiliation:
West Park Hospital, Epsom, Surrey KT19 8PB
*
∗ Correspondece
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

The response to the dexamethasone suppression test (DST) was examined in 543 patients suffering from major depressive illness and 246 healthy controls, from 13 research centres, representing 12 different countries, in a World Health Organization Collaborative Study. In almost all the centres, the post-dexamethasone plasma Cortisol concentration was significantly higher in the patients than in the controls. Although there is variation between centres, this abnormal response to the DST was shown to be frequent in patients from widely different geographical areas.

Information

Type
Research Article
Copyright
Copyright © 1987 The Royal College of Psychiatrists 

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.